Eiger BioPharmaceuticals, Inc.
AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA

Last updated:

Abstract:

Methods of treating hyperinsulinemic hypoglycemia (HH), including post-bariatric hypoglycemia (PBH) are provided. In some embodiments, the method comprises administering to a subject having HH a buffered liquid formulation composition.

Status:
Application
Type:

Utility

Filling date:

15 Oct 2019

Issue date:

4 Nov 2021